Northwest Receives US Patent for Automation of DCVax Manufacturing

Northwest Biotherapeutics, Inc. announced Friday that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company’s DCVax therapeutic cancer vaccines.
Yahoo!